🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Comparator: MK0518 combination therapy

Found 12 matching trials

A Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 Versus Efavirenz in Treatment Naive HIV-Infected Patients, Each in Combination With TRUVADA (0518-021 EXT)

PHASE3

This study will investigate the safety and efficacy of MK-0518 versus efavi...

Status

Completed

Location

Multiple Locations

Start Date

2006-08

Trial ID

NCT00369941

Treatments Being Tested

MK-0518 Comparator: efavirenz Comparator: Truvada Comparator: Placebo to MK-0518 Comparator: Placebo to efavirenz

Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)

PHASE3

To evaluate the safety and efficacy of reformulated raltegravir (MK-0518) 1...

Status

Completed

Location

Multiple Locations

Start Date

2014-05-23

Trial ID

NCT02131233

Treatments Being Tested

Reformulated Raltegravir Raltegravir TRUVADA™Placebo to Reformulated Raltegravir Placebo to Raltegravir

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)

PHASE3

This study will investigate the safety and efficacy of raltegravir as a the...

Status

Completed

Location

Multiple Locations

Start Date

2006-02

Trial ID

NCT00293267

Treatments Being Tested

raltegravir potassium Comparator: Placebo

Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED)

PHASE2

This study will investigate the safety and efficacy of different doses of a...

Status

Completed

Location

Multiple Locations

Start Date

2005-03

Trial ID

NCT00105157

Treatments Being Tested

Comparator: MK0518 MK0518 MK0518 Placebo

A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)

PHASE3

This study will investigate the safety and efficacy of raltegravir as a the...

Status

Completed

Location

Multiple Locations

Start Date

2006-02

Trial ID

NCT00293254

Treatments Being Tested

raltegravir potassium Comparator: placebo

A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)

PHASE2

This is a study that will investigate the safety and efficacy of an investi...

Status

Completed

Location

Multiple Locations

Start Date

2005-01

Trial ID

NCT00100048

Treatments Being Tested

Comparator: MK0518 monotherapy Comparator: MK0518 combination therapy Comparator: efavirenz Comparator: tenofovir Comparator: lamivudine Placebo monotherapy

Raltegravir One Thousand Two Hundred vs Darunavir-cb in Immnunosupressed Patients: ROTDIP Study

PHASE4

Multicenter, randomized, open label pilot clinical trial with two parallel ...

Status

Unknown

Location

Multiple Locations

Start Date

2019-04

Trial ID

NCT03842488

Treatments Being Tested

Experimental: RAL QD Active comparator: DRV/cb

A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)

PHASE3

A study to evaluate the safety, tolerability and efficacy of once daily Ral...

Status

Terminated

Location

Multiple Locations

Start Date

2008-09

Trial ID

NCT00745823

Treatments Being Tested

Comparator: Raltegravir 400 mg b.i.d.Experimental: Raltegravir 800 mg q.d.TRUVADA™

Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection

PHASE4

2\. Objectives 1. To determine the vitamin D status of African-American HI...

Status

Unknown

Location

Multiple Locations

Start Date

2011-05

Trial ID

NCT01343225

Treatments Being Tested

atripla darunavir ritonavir raltegravir

Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection

PHASE2

The current available antiretroviral (ARV) agents make possible a successfu...

Status

Terminated

Location

Fundação Bahiana de Infectologia/SEI

Start Date

2015-06-01

Trial ID

NCT01854762

Treatments Being Tested

Raltegravir Lopinavir/Ritonavir

Previous Next